SCHEMBL2746597

SCHEMBL2746597

NC(=O)OCCCCOC(N)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.52
LMNA P02545 3/20 0.52
CHRM2 P08172 2/20 0.52
CHRM4 P08173 2/20 0.52
CHRM5 P08912 2/20 0.52
CHRM1 P11229 2/20 0.52
CHRM3 P20309 2/20 0.52
CHRNB2 P17787 2/20 0.52
CHRNA4 P43681 2/20 0.52
HTR1A P08908 1/20 0.52
CYP2C19 P33261 1/20 0.52
CHRNA7 P36544 1/20 0.52
ALOX15 P16050 1/20 0.50
CHRNB4 P30926 1/20 0.44
CHRNA3 P32297 1/20 0.44
ALDH1A1 P00352 2/20 0.42
CYP3A4 P08684 1/20 0.42
NAAA Q02083 1/20 0.39
TDP1 Q9NUW8 1/20 0.37
EPHX1 P07099 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5721317 0.97 TSHR (0.50) TSHRLMNACHRM2CHRM4CHRM5
SCHEMBL5721434 0.97 TSHR (0.50) TSHRLMNACHRM2CHRM4CHRM5
SCHEMBL2746089 0.97 TSHR (0.50) TSHRLMNACHRM2CHRM4CHRM5
SCHEMBL2136691 0.97 TSHR (0.50) TSHRLMNACHRM2CHRM4CHRM5
SCHEMBL31296577 0.97 TSHR (0.50) TSHRLMNACHRM2CHRM4CHRM5
SCHEMBL2059697 0.97 TSHR (0.50) TSHRLMNACHRM2CHRM4CHRM5
SCHEMBL2139712 0.97 TSHR (0.50) TSHRLMNACHRM2CHRM4CHRM5
SCHEMBL2136844 0.97 TSHR (0.50) TSHRLMNACHRM2CHRM4CHRM5
Ammonia Solution, Strong SCHEMBL10899519 0.94 LMNA (0.48) TSHRLMNACHRM2CHRM4CHRM5
Ammonia Solution, Strong SCHEMBL322522 0.94 LMNA (0.48) TSHRLMNACHRM2CHRM4CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023161645-A2 PHARMACEUTICAL COMPOSITIONS FOR VAPORIZATION AND INHALATION GROW BIOTECH PLC (GB) 2023-08-31 WO claimed
EP-2841496-B1 RUBBER COMPOSITIONS ALLNEX GERMANY GMBH (DE) 2022-10-26 EP claimed
US-8476428-B2 Method of preparing cyclic carbonates, cyclic carbamates, cyclic ureas, cyclic thiocarbonates, cyclic thiocarbamates, and cyclic dithiocarbonates INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2013-07-02 US claimed
US-20120202993-A1 METHOD OF PREPARING CYCLIC CARBONATES, CYCLIC CARBAMATES, CYCLIC UREAS, CYCLIC THIOCARBONATES, CYCLIC THIOCARBAMATES, AND CYCLIC DITHIOCARBONATES INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2012-08-09 US claimed
US-20100280242-A1 Method of Preparing Cyclic Carbonates, Cyclic Carbamates, Cyclic Ureas, Cyclic Thiocarbonates, Cyclic Thiocarbamates, and Cyclic Dithiocarbonates INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2010-11-04 US claimed
JP-3558134-B2 2004-08-25 JP claimed
US-5869416-A Electrode ink for membrane electrode assembly THE DOW CHEMICAL COMPANY (US) 1999-02-09 US claimed
EP-0853824-A2 FLOW FIELD STRUCTURES FOR MEMBRANE ELECTRODE ASSEMBLIES OF FUEL CELLS THE DOW CHEMICAL COMPANY (US) 1998-07-22 EP claimed
US-5702755-A Process for preparing a membrane/electrode assembly THE DOW CHEMICAL COMPANY (US) 1997-12-30 US claimed
WO-1997013287-A9 FLOW FIELD STRUCTURES FOR MEMBRANE ELECTRODE ASSEMBLIES OF FUEL CELLS 1997-07-03 WO claimed
WO-1997013287-A2 FLOW FIELD STRUCTURES FOR MEMBRANE ELECTRODE ASSEMBLIES OF FUEL CELLS THE DOW CHEMICAL COMPANY (US) 1997-04-10 WO claimed
US-20240115715-A1 PHARMACEUTICAL COMPOSITIONS FOR VAPORIZATION AND INHALATION GROW BIOTECH PLC (GB) 2024-04-11 US disclosed
CN-116804123-A PET film ultraviolet light curing (UV) hardening liquid for folding screen 中国石油大学(华东) 2023-09-26 CN disclosed
WO-2023161645-A2 PHARMACEUTICAL COMPOSITIONS FOR VAPORIZATION AND INHALATION GROW BIOTECH PLC (GB) 2023-08-31 WO disclosed
EP-3620308-B1 PNEUMATIC TIRE GOODYEAR TIRE & RUBBER (US) 2022-12-21 EP disclosed
WO-1998045503-A1 ELECTROLYSIS OF ALKALI METAL HALIDE BRINES USING OXYGEN CATHODE SYSTEMS THE DOW CHEMICAL COMPANY (US) 1998-10-15 WO disclosed
EP-0853824-A2 FLOW FIELD STRUCTURES FOR MEMBRANE ELECTRODE ASSEMBLIES OF FUEL CELLS THE DOW CHEMICAL COMPANY (US) 1998-07-22 EP disclosed
US-5702755-A Process for preparing a membrane/electrode assembly THE DOW CHEMICAL COMPANY (US) 1997-12-30 US disclosed
WO-1997013287-A9 FLOW FIELD STRUCTURES FOR MEMBRANE ELECTRODE ASSEMBLIES OF FUEL CELLS 1997-07-03 WO disclosed
WO-1997013287-A2 FLOW FIELD STRUCTURES FOR MEMBRANE ELECTRODE ASSEMBLIES OF FUEL CELLS THE DOW CHEMICAL COMPANY (US) 1997-04-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202993-A1 METHOD OF PREPARING CYCLIC CARBONATES, CYCLIC CARBAMATES, CYCLIC UREAS, CYCLIC THIOCARBONATES, CYCLIC THIOCARBAMATES, AND CYCLIC DITHIOCARBONATES CPS1, TST, CTH TSHR 232/4885LMNA 4184/4885CHRM2 2059/4885
US-20100280242-A1 Method of Preparing Cyclic Carbonates, Cyclic Carbamates, Cyclic Ureas, Cyclic Thiocarbonates, Cyclic Thiocarbamates, and Cyclic Dithiocarbonates CPS1, TST, CTH TSHR 232/4885LMNA 4184/4885CHRM2 2059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.